Previous close | 7.07 |
Open | 7.30 |
Bid | 6.95 |
Ask | 8.25 |
Strike | 45.00 |
Expiry date | 2026-01-16 |
Day's range | 7.30 - 7.30 |
Contract range | N/A |
Volume | |
Open interest | 5.95k |
Bristol Myers (BMY) announces positive data from three studies evaluating CAR T cell therapy Breyanzi (liso-cel) and three updated analyses on studies evaluating Opdivo at ASCO.
PRINCETON, N.J., June 04, 2024--Bristol Myers Squibb Announces Opdivo (nivolumab) Plus Yervoy (ipilimumab) Significantly Improved Overall Survival Compared to Lenvatinib or....
The simplest way to benefit from a rising market is to buy an index fund. But if you buy individual stocks, you can do...